MedTech health and data company AcuityMD scores $45M and more digital health fundings

2024-06-05
来源: mobihealthnews
Photo: Tassii/Getty Images
AcuityMD, which offers a health data tool for the medical technology industry, announced it secured $45 million in funding, bringing its total raise to more than $83 million.
ICONIQ Growth led the round, with participation from Stepstone Group, Atreides Management, Benchmark Capital, Artisanal Ventures and Redpoint Ventures.
The Boston-based company's platform combines medical device data from sales to patient outcomes so manufacturers can track the performance of their products.
The company will use the funds to expand its product's reach with MedTech manufacturers.
"We are fortunate to work with fantastic financial partners as well as experienced MedTech industry executives who broaden the perspective of our Customer Advisory Board," Michael Monovoukas, CEO and cofounder of AcuityMD, said in a statement.
"With this additional capital, we aim to launch three new products to general availability, expand our pipeline management solution to more customers and grow our engineering and product teams by 70% by the end of 2024 to support our mission of accelerating the adoption of cutting-edge medical technology."
Digital heart and lung disease health startup Eko Health announced it raised $41 million in Series D financing.
ARTIS Ventures, NTTVC, Questa Capital and Highland Capital Partners participated in the round.
California-based Eko Health combines ECG-enabled digital stethoscope devices with monitoring and analysis algorithms to help providers detect heart rhythm abnormalities and other heart and lung diseases.
The company will use the funds to scale access to its early disease detection platform globally.
"Just as Ring transformed doorbells into home security systems, Eko has reinvented the world’s most ubiquitous medical tool into a powerful early disease detection platform, creating the world’s largest install base of professional AI-enabled cardiology devices," Connor Landgraf, CEO and cofounder of Eko Health, said in a statement.
Tags: AcuityMD, Eko Health
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。